KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) FCF Margin (2020 - 2025)

Hims & Hers Health's FCF Margin history spans 6 years, with the latest figure at 20.7% for Q4 2025.

  • For Q4 2025, FCF Margin fell 3991.0% year-over-year to 20.7%; the TTM value through Dec 2025 reached 3.15%, down 1310.0%, while the annual FY2025 figure was 3.15%, 1310.0% down from the prior year.
  • FCF Margin for Q4 2025 was 20.7% at Hims & Hers Health, down from 20.01% in the prior quarter.
  • Across five years, FCF Margin topped out at 20.4% in Q3 2024 and bottomed at 31.9% in Q1 2021.
  • The 5-year median for FCF Margin is 3.33% (2022), against an average of 0.73%.
  • The largest annual shift saw FCF Margin skyrocketed 2775bps in 2022 before it plummeted -3991bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 4.77% in 2021, then increased by 0bps to 4.74% in 2022, then skyrocketed by 282bps to 8.64% in 2023, then soared by 122bps to 19.21% in 2024, then tumbled by -208bps to 20.7% in 2025.
  • Per Business Quant, the three most recent readings for HIMS's FCF Margin are 20.7% (Q4 2025), 20.01% (Q3 2025), and 4.29% (Q2 2025).